A PHASE II CLINICAL TRIAL OF CELECOXIB (OR NSAID) IN SUBJECTS WITH ACT-261085183

$0N01FY2006CANIH

University Of Alabama At Birmi

Investigators

Craig A Elmetscontact

View original record on NIH RePORTER →